Access to high-cost targeted treatments varies for lung cancer
(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from
Updated on: December 22,2023
22
Access to high-cost targeted treatments varies for lung cancer
(HealthDay)—Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in theJournal of the National Cancer Institute.Cathy J. Bradley, Ph.D., from
Updated on:December 22,2023
22
